Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
+0.40 (1.37%)
At close: Jul 16, 2024, 4:01 PM
-0.13 (-0.44%)
Pre-market: Jul 17, 2024, 6:51 AM EDT

Company Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally.

The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands.

In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems.

The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE.

Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer Inc.
Pfizer logo
Country United States
Founded 1849
Industry Drug Manufacturers - General
Sector Healthcare
Employees 88,000
CEO Dr. Albert Bourla D.V.M., Ph.D.

Contact Details

66 Hudson Boulevard East
New York, New York 10001-2192
United States
Phone (212) 733-2323

Stock Details

Ticker Symbol PFE
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000078003
CUSIP Number 717081103
ISIN Number US7170811035
Employer ID 13-5315170
SIC Code 2834

Key Executives

Name Position
Dr. Albert Bourla D.V.M., Ph.D. Chairman of the Board and Chief Executive Officer
David M. Denton Chief Financial Officer and Executive Vice President
Dr. Mikael Dolsten M.D., Ph.D. Chief Scientific Officer and President of Research and Development
Douglas M. Lankler Executive Vice President and General Counsel
Aamir Malik Executive Vice President and Chief U.S. Commercial Officer
Jennifer B. Damico Senior Vice President, Controller and Principal Accounting Officer
Lidia L. Fonseca Executive Vice President and Chief Digital and Technology Officer
Francesca M. DeMartino Chief Investor Relations Officer
Rady A. Johnson Executive Vice President and Chief Compliance, Quality and Risk Officer
Andreas J. Panayiotou Global Chief Marketing Officer

Latest SEC Filings

Date Type Title
Jul 10, 2024 8-K Current Report
Jul 1, 2024 8-K Current Report
Jun 11, 2024 11-K Annual report of employee stock purchase, savings and similar plans
Jun 11, 2024 11-K Annual report of employee stock purchase, savings and similar plans
May 31, 2024 SD Form - SD
May 22, 2024 8-K Current Report
May 9, 2024 S-8 Securities to be offered to employees in employee benefit plans
May 8, 2024 10-Q Quarterly Report
May 1, 2024 8-K Current Report
Apr 29, 2024 8-K Current Report